CRYOPORT, INC. Lease, Cost
CRYOPORT, INC. (CYRX) reported Lease, Cost of $4.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- CRYOPORT, INC. lease, cost for the quarter ending 2026-06-30 was $1.95M, a 13.20% decline year-over-year.
- CRYOPORT, INC. lease, cost for the quarter ending 2026-03-31 was $2.13M, a 0.28% decline year-over-year.
- CRYOPORT, INC. lease, cost for the quarter ending 2025-12-31 was $2.16M, a 29.14% increase year-over-year.
- CRYOPORT, INC. lease, cost for the quarter ending 2025-09-30 was $2.27M, a 45.76% increase year-over-year.
- CRYOPORT, INC. lease, cost for fiscal 2025 was $8.81M, a 45.26% increase from fiscal 2024.
- CRYOPORT, INC. lease, cost for fiscal 2024 was $6.06M, a 13.99% increase from fiscal 2023.
- CRYOPORT, INC. lease, cost for fiscal 2023 was $5.32M, a 4.95% decline from fiscal 2022.
- CRYOPORT, INC. lease, cost for fiscal 2022 was $5.60M, a 20.99% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.08M 10-Q · filed 2026-08-06 | $6.23M derived: sum of 3 quarters · filed 2026-08-06 | $8.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.13M 10-Q · filed 2026-05-05 | $4.29M derived: sum of 2 quarters · filed 2026-05-05 | $6.56M derived: sum of 3 quarters · filed 2026-05-05 | $8.80M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.43M derived: sum of 2 quarters · filed 2026-03-05 | $6.67M derived: sum of 3 quarters · filed 2026-08-06 | $8.81M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.51M derived: sum of 2 quarters · filed 2026-08-06 | $6.65M 10-Q · filed 2025-11-06 | $8.32M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.38M 10-Q · filed 2026-08-06 | $6.05M derived: sum of 3 quarters · filed 2026-08-06 | $7.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.13M 10-Q · filed 2026-05-05 | $3.81M derived: sum of 2 quarters · filed 2026-05-05 | $5.36M derived: sum of 3 quarters · filed 2026-05-05 | $6.75M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.23M derived: sum of 2 quarters · filed 2026-03-05 | $4.61M derived: sum of 3 quarters · filed 2026-03-05 | $6.06M 10-K · filed 2026-03-05 | $8.89M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.94M derived: sum of 2 quarters · filed 2025-11-06 | $4.39M 10-Q · filed 2025-11-06 | $6.58M 10-Q · filed 2024-11-07 | $4.24M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.83M 10-Q · filed 2025-08-12 | $4.24M 10-Q · filed 2024-08-08 | $2.69M derived: sum of 3 quarters · filed 2026-03-05 | $4.60M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-03-31 | $1.45M 10-Q · filed 2025-05-08 | $2.15M 10-Q · filed 2024-05-08 | $1.30M derived: sum of 2 quarters · filed 2026-03-05 | $3.22M derived: sum of 3 quarters · filed 2026-03-05 | $4.95M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.77M derived: sum of 2 quarters · filed 2026-03-05 | $3.50M derived: sum of 3 quarters · filed 2026-03-05 | $5.32M 10-K · filed 2026-03-05 | $7.57M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.65M derived: sum of 2 quarters · filed 2024-11-07 | $5.47M 10-Q · filed 2024-11-07 | $7.08M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.55M 10-Q · filed 2024-08-08 | $5.16M derived: sum of 3 quarters · filed 2025-03-07 | $6.59M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $1.82M 10-Q · filed 2024-05-08 | $3.43M derived: sum of 2 quarters · filed 2025-03-07 | $4.86M derived: sum of 3 quarters · filed 2025-03-07 | $6.16M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $3.04M derived: sum of 2 quarters · filed 2025-03-07 | $4.34M derived: sum of 3 quarters · filed 2025-03-07 | $5.60M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.73M derived: sum of 2 quarters · filed 2023-11-09 | $3.98M 10-Q · filed 2023-11-09 | $5.40M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.56M 10-Q · filed 2023-08-09 | $3.97M derived: sum of 3 quarters · filed 2024-03-13 | $7.18M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-04 | $2.67M derived: sum of 2 quarters · filed 2024-03-13 | $5.88M derived: sum of 3 quarters · filed 2024-03-13 | $5.88M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $4.62M derived: sum of 2 quarters · filed 2024-03-13 | $4.62M derived: sum of 3 quarters · filed 2024-03-13 | $4.63M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $3.21M derived: sum of 2 quarters · filed 2022-11-04 | $3.21M 10-Q · filed 2022-11-04 | $3.21K 10-Q · filed 2021-11-04 | $5.11M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $1.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $2.03K 10-Q · filed 2021-08-06 | $1.90M derived: sum of 3 quarters · filed 2023-02-28 | $1.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $940.00 10-Q · filed 2021-05-06 | $1.90M derived: sum of 2 quarters · filed 2023-02-28 | $1.90M derived: sum of 3 quarters · filed 2023-02-28 | $1.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.90M derived: sum of 2 quarters · filed 2023-02-28 | $1.90M derived: sum of 3 quarters · filed 2023-02-28 | $1.90M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $385.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $711.00 derived: sum of 2 quarters · filed 2021-11-04 | $1.01K 10-Q · filed 2021-11-04 | $1.01M 10-Q · filed 2020-11-06 | $255.90K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $326.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $624.00 10-Q · filed 2021-08-06 | $623.93K 10-Q · filed 2020-08-10 | $255.52K derived: sum of 3 quarters · filed 2022-02-28 | $485.51K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $298.00 10-Q · filed 2021-05-06 | $298.32K 10-Q · filed 2020-05-08 | $255.19K derived: sum of 2 quarters · filed 2022-02-28 | $485.18K derived: sum of 3 quarters · filed 2022-02-28 | $643.89K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $254.89K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $484.88K derived: sum of 2 quarters · filed 2022-02-28 | $643.59K derived: sum of 3 quarters · filed 2022-02-28 | $771.00K 10-K · filed 2022-02-28 | $770.46K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $229.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $388.70K derived: sum of 2 quarters · filed 2019-11-12 | $516.11K 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $158.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $286.12K 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | $127.41K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |